Internal Medicine

For many, cardiovascular disease can be seen as mostly an issue facing men. However, work has been done to raise the education of women to help ensure their health as well.

Crohn’s disease can impact brain function in the capacities of slower response times than individuals without Crohn’s, according to findings published in UEG Journal.

There has been plenty of research to show that rehabilitation can help with the cognitive function of patients with multiple sclerosis. A recent study looked at whether advanced imaging can determine whether some patients will respond better to the therapy than others.

In adult patients neuromyelitis optica is considered a rare enough condition. It is even more rare in children making the diagnosis and treatment a longer and more careful process.

At the Heart Failure Society of America's 20th Annual Scientific Meeting, Pieter Muntendam, MD, scPharmaceuticals, discussed his work in developing a hospital strength treatment option for patients with fluid overload using the well known drug furosemide, now for subcutaneous administration.

Investigators found poor asthma control in obese or overweight patients despite optimal treatment and significantly higher BMI values in those with uncontrolled asthma than in those with partially or totally controlled asthma.

While there's no yet proven treatment for heart failure with preserved ejection fraction, the team is really aiming to understand the pathophysiology to design better targeted treatments.

Study results presented at the 2016 Heart Failure Society of America Scientific Meeting show that treatment with omecantiv mecarbil improved cardiac function and quality of life in patients with heart failure.

At the moment the best way to get a diagnosis of multiple sclerosis is through a brain scan. A team in Tennessee is working to improve that with a blood test that could find the condition sooner allowing for treatment to begin faster.

While neurologists may be able to successfully diagnose progressive multifocal leukoencephalopathy it may take a more specialized health care professional to effectively treat the condition.

It has been a few years now since Tecfidera was approved by the US Food and Drug Administration. In that time there has bee continued research which has shown positive results for patients.

As robotic surgery has become more popular in fields like urology and gynecology questions have been raised about who is most likely to undergo these procedures and why that is the case.

There is a known connection between atrial fibrillation and stroke risk. Finding the best way to handle this connection can determine the success of care and the quality of life for patients.

Patients diagnosed with atrial fibrillation will often need treatment extending over a long period of time. In many cases ablation can be the best way to manage their symptoms requiring the work of an electrophysiologist.

We present a round-up of recent news, trial results, and other developments for infectious disease experts and other physicians who treat patients with C. difficile infection.

Pain management is everyone's job. It's a human problem.

There is a lot of regulatory scrutiny, media attention, and confusion about managing pain, so patient education should be at the forefront of physicians' minds.

In the past 15 years, no new topical AD treatments have been approved. Crisaborole, however, could be an efficient, safe, non-steoidal treatment option, according to the results of two recent phase III studies.

At The European Society of Cardiology Congress 2016 (ESC), Ibrahim Danad, MD, VU University Medical Center, Amsterdam, Netherlands, explained the results from his team's PACIFIC trial, which assessed two non-invasive coronary artery imaging tools: positon emission tomography (PET) and single photon emission computed tomography (SPECT).

At the European Society of Cardiology Congress 2016 (ESC) in Rome, Italy, Anselm Gitt, MD discussed the DYSIS program, which was designed to get an idea to see how patients were treated for secondary prevention, focusing on dyslipidemia patients.

Renato Delascio Lopes, MD, Duke University Medical Center, discussed at the European Society of Cardiology Congress 2016 (ESC), the progress of anticoagulant therapies for patients.

Christopher Granger, MD, Duke University Medical Center also spoke at the European Society of Cardiology COngress 2016 about the issues surrounding patients' tolerability of anticoagulants and other drugs.

Statins should not be physicians' first option in treating all patients at high risk of cardiovascular disease, according to new European treatment guidelines.

An international team looked at oral anticoagulants and decided dabigatran is the best for stroke prevention in non-valvular atrial fibrillation.

Lung cancer patients who develop sinus tachycardia due to some treatments for their cancer can successfully reduce their heart rates with ivabradine, researchers in Romania report.